IP firm believe the newly established court is interpreting the public access rules too restrictively, looks to the EPO as a ‘paragon of openness’ in this area | 2d
IP firm believe the newly established court is interpreting the public access rules too restrictively, looks to the EPO as a ‘paragon of openness’ in this area | 2d
Service aims to settle IP disputes in a single process avoiding the expense and complexity of litigation | 1w
USPTO seeks to encourage “broader participation” in bar | 1w
Data specialist Maureen Daly joins from Beauchamps as Pinsents moves to build Europe tech and science sector offering | 2w
Luxury Law is a comprehensive guide providing answers and insight into how luxury businesses can protect their brands in a range of jurisdictions. | 1yr
Editors:
IP filings have “braved” the pandemic, but WIPO director general warns of geopolitical instability and an uncertain economic outlook | 3w
Quartet of patent experts joins recent Cooley hire Amy Baker Mandragouras to boost Foley’s life sciences IP practice | 1mo
Join brand protection managers, law enforcement and technology innovators on 18 October to share best practice in the fight against counterfeits | 1mo
Rouse beefs up its intellectual property enforcement team with two new appointments in response to client need amid the changing anti-counterfeiting landscape | 1mo
Eve Alexander, head of intelligence analysis at the UK’s Intellectual Property Office, examines the sweeping changes in the counterfeiting landscape over the last decade | 2mos
Hemmie Chang joins to lead new life sciences-focused office | 2mos
Veteran litigators join amid uptick in federal and state regulatory scrutiny facing product manufacturers | 2mos
Move marks latest round in Covid-19 mRNA vaccine patent litigation battle | 3mos
Nine weeks in and figures reveal the UP is proving popular with roughly 700 requests a week | 3mos
Cincinnati-based firm adds 19 lawyers and nearly two dozen business professionals through merger with Mateer & Harbert | 3mos
Five patents relating to groundbreaking gene editing technology cannot be quashed by interference proceedings used in previous US patent system | 4mos
Sapna Dutta to succeed Elizabeth Messud as FTSE 100 company’s top lawyer in October | 4mos
Andrei Iancu and Kathleen O’Malley join from Irell & Manella to bolster US firm’s patent practice in Los Angeles and Washington DC | 4mos
Veteran government litigator Coke Morgan Stewart joins firm’s Washington DC office | 4mos
Legislation to tackle uncertainty surrounding what is patent-eligible subject matter and reforming the USPTO’s post grant review process was introduced last week in the US senate | 5mos
Seven partners among those joining transatlantic firm in Atlanta and Washington DC | 5mos